🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.

Recruitingn/aAges 18 Years - anyAllUniwersytecki Szpital Kliniczny w Opolu
NCT06174610 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to determine whether there is a correlation between changes in the renal resistive index and the restoration of kidney function in critically ill patients undergoing continuous renal replacement therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All ICU patients undergoing CRRT due to AKI Exclusion Criteria: * age \<18 years * pregnancy * history of chronic kidney disease in stage 4 or 5 * post-kidney transplant status * mechanical circulatory support * occurrence of one or more conditions preventing reliable RRI measurement in both kidneys: * challenging technical conditions of ultrasound examination, hindering proper visualization of the kidney * post-kidney injury in grade III and higher, according to AAST * advanced parenchymal kidney pathology: atrophy, hypoplasia, cirrhosis, extensive ischemia (more than 2/3 of the parenchyma), * kidney diseases preventing parenchyma identification: advanced cancer (stage above T1 according to TNM), certain forms of polycystic kidney disease * inflammatory kidney diseases * obstructive uropathy * renal vascular pathologies: renal vein thrombosis, significant stenosis (\>60%), and renal artery occlusion.
💊

What it tests

  • Measurement of Renal Resistive Index
📍

Where

1 site
Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu
Opole, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy